1. Home
  2. ACET vs ALAR Comparison

ACET vs ALAR Comparison

Compare ACET & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$7.00

Market Cap

69.6M

Sector

Health Care

ML Signal

HOLD

Logo Alarum Technologies Ltd.

ALAR

Alarum Technologies Ltd.

HOLD

Current Price

$7.11

Market Cap

58.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
ALAR
Founded
1947
2013
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
69.6M
58.8M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
ACET
ALAR
Price
$7.00
$7.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$56.00
$27.00
AVG Volume (30 Days)
111.8K
28.2K
Earning Date
03-12-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$31.17
Revenue Next Year
N/A
$30.14
P/E Ratio
N/A
$44.31
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$5.45
52 Week High
$9.05
$18.00

Technical Indicators

Market Signals
Indicator
ACET
ALAR
Relative Strength Index (RSI) 45.55 48.77
Support Level $6.54 $6.34
Resistance Level $8.34 $8.00
Average True Range (ATR) 0.44 0.46
MACD -0.06 0.06
Stochastic Oscillator 17.94 47.10

Price Performance

Historical Comparison
ACET
ALAR

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.

Share on Social Networks: